Boston Scientific Corporation announced today a decision by the United States District Court in Delaware. The case involves a patent owned by Johnson & Johnson and Boston Scientific’s NIR® stent product. In the decision, the Judge granted Johnson & Johnson’s motion for entry of final judgment and denied Boston Scientific’s motion for a new trial. In 2000, a jury awarded Johnson & Johnson $324 million in damages based on Boston Scientific’s sale of the NIR stent. The Court also awarded pre-judgment interest at prime rate based on after-tax damages.Today’s Order indicated that the Court will enter final judgment on September 30, 2008.
Boston Scientific no longer sells the NIR stent. The Company announced that it will appeal this decision.
Boston Scientific is a worldwide developer, manufacturer and marketer of medical devices whose products are used in a broad range of interventional medical specialties. For more information, please visit: www.bostonscientific.com.